Q2 2023 EPS Estimates for Amarin Co. plc (NASDAQ:AMRN) Cut by Northland Capmk

Amarin Co. plc (NASDAQ:AMRN – Free Report) – Research analysts at Northland Capmk cut their Q2 2023 earnings per share (EPS) estimates for Amarin in a report released on Wednesday, July 19th. Northland Capmk analyst C. Byrnes now expects that the biopharmaceutical company will post earnings of ($0.06) per share for the quarter, down from […]

Related Keywords

United States ,Canada ,Lebanon ,United Arab Emirates ,Northland Capmk ,Amarin Co ,Millennium Management ,Morgan Stanley ,Goldman Sachs Group ,Amarin Corporation ,Nasdaq ,Free Report ,Get Free Report ,Sigma Investments ,Sarissa Capital Management ,Capital Management ,United Arab ,Amarin Daily ,Amarin ,Nasdaq Amrn ,Amrn ,Medical ,Earnings Estimates ,